← Back to Clinical Trials
Recruiting NCT07154550

NCT07154550 Comparing Outcomes and Complications Following Mastisol Application for Clubfoot Casting

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07154550
Status Recruiting
Phase
Sponsor University of Wisconsin, Madison
Condition Club Foot
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2026-02-11
Primary Completion 2032-11

Eligibility & Interventions

Sex All sexes
Min Age 0 Weeks
Max Age 12 Weeks
Study Type INTERVENTIONAL
Interventions
Mastisol

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2026-02-11 with a primary completion date of 2032-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to assess if the application of Mastisol, a liquid adhesive, improves outcomes during bilateral clubfoot casting and reduces complications and development of complex clubfoot for the duration of their casting and up to 5 years follow-up.

Eligibility Criteria

Inclusion Criteria: * Patients with bilateral clubfeet * Starting standard of care treatment with the Ponseti method between 0-12 weeks of age * For patients born pre-maturely their eligibility age will be based on a corrected gestational age * Patients for whom at least one parent/guardian is able to converse, read, and write in English Exclusion Criteria: * Patients who do not have bilateral clubfoot * Patients who are starting treatment for clubfoot after 12 weeks of age * Patients whose parents/guardians are unable to converse, read, and write in English * Patients whose parents/guardian do not provide or are not able to provide informed consent

Contact & Investigator

Central Contact

Ava Barker

✉ barker@ortho.wisc.edu

📞 (608)-263-2356

Principal Investigator

Patrick Touhy, MD

PRINCIPAL INVESTIGATOR

UW School of Medicine and Public Health

Frequently Asked Questions

Who can join the NCT07154550 clinical trial?

This trial is open to participants of all sexes, aged 0 Weeks or older, up to 12 Weeks, studying Club Foot. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07154550 currently recruiting?

Yes, NCT07154550 is actively recruiting participants. Contact the research team at barker@ortho.wisc.edu for enrollment information.

Where is the NCT07154550 trial being conducted?

This trial is being conducted at Madison, United States.

Who is sponsoring the NCT07154550 clinical trial?

NCT07154550 is sponsored by University of Wisconsin, Madison. The principal investigator is Patrick Touhy, MD at UW School of Medicine and Public Health. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology